Invivoscribe launches LymphoTrack Flex Suite for molecular clonality testing

Invivoscribe has announced the launch of the LymphoTrack Flex Suite, an integrated next-generation sequencing (NGS) solution designed to identify and monitor gene rearrangements in immunoglobulins and T-cell receptors.

The suite aims to meet the growing demand for standardized, high-throughput workflows in oncology research centers. It integrates seven molecular targets into a single automation-ready workflow, utilizing massively parallel multiplexing and bioinformatics to provide objective analysis of clonal sequences and measurable residual disease (MRD).